New study reveals who is at risk for brain bleeding after stroke drug
NCT ID NCT06337175
First seen Sep 30, 2025 · Last updated Jun 16, 2026 · Updated 34 times
Summary
This study looked at 600 stroke patients in the Middle East who received the clot-busting drug alteplase. Researchers wanted to find out which patient traits or treatment delays might predict different types of brain bleeding after the drug. The goal is to help doctors better identify who is at risk, so they can use the drug more safely.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ISCHEMIC STROKE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Kafr Elsheikh University Hospital
Kafr ash Shaykh, 33155, Egypt
Conditions
Explore the condition pages connected to this study.